Effects of Gomishi and Shosaiko-to on lipid peroxidation of rat brain]

Gomishi and Shosaiko-to were administered to the rats at a dose of 10-100 mg/kg daily for 2 weeks, and their effects on lipid peroxidation of rat brain were compared with that of alpha-tocopherol. Administration of Gomishi and Shosaiko-to showed almost the same suppressive action on the lipid peroxidation. Gomishi and Shosaiko-to exhibited a radical-trapping action on a stable free radical, 1, 1-diphenyl-2-picrylhydrazyl (DPPH), which was estimated photometrically. The effects of Gomishi or Shosaiko-to at concentrations of 10(-3) to 10(-5)g/ml on lipid peroxidation of rat brain homogenates were investigated. The lipid peroxidation was inhibited by the addition of these drugs, and the suppressive effect was also dependent on the concentration. These suppressive effects with Shosaiko-to were stronger than those of Gomishi. These results suggest that the radical trapping action of Gomishi or Shosaiko-to is the likely mechanism suppressing brain lipid peroxidation; Particularly, the suppressive effect on the brain's lipid peroxidation by Shosaiko-to is at least in part due to its radical trapping action and inhibition of O2-. production.     

Action of the novel antioxidants 4GBE43 and 2BBE43 against lipid peroxidation.

The action and the effect of the newly synthesized compounds 4GBE43 [N-(1,2-diethyltetrahydro-1H-pyrazol-4-yl)-4-[(2E)-3,7-diethyl-2,6-octadienyl] oxybenzamide] and 2BBE43 [2-(benzyloxy)-N-(1,2-diethyltetrahydro-1H-pyrazol-4-yl)benzamide] against lipid peroxidation were studied. 4GBE43 and 2BBE43 quenched the ESR signal of diphenylpicrylhydrazyl (DPPH), suggesting that 4GBE43 and 2BBE43 act as scavengers of free radicals and that each compound quenched 6 free radical molecules. These compounds suppressed the oxidation of methyl linoleate emulsions and soybean phosphatidylcholine liposomes by a free radical initiator, suggesting that these compounds quench the lipid peroxyl radical. 4GBE43 and 2BBE43 also suppressed the spontaneous oxidation of rat brain homogenates. The inhibitory effect of 2BBE43 was of the same order of magnitude (IC50) as that of probucol. The IC50 of 4GBE43 was on the same order of magnitude as that of alpha-tocopherol. However, 4GBE43 at 10(-4)-10(-5) M completely inhibited peroxidation, showing it to be more effective than alpha-tocopherol. These results suggest that 4GBE43 and 2BBE43 act as antioxidants by quenching the lipid peroxyl radical.     

Inhibition by uric acid of free radicals that damage biological molecules

To clarify the antioxidative role of uric acid, its ability to scavenge carbon-centered and peroxyl radicals and its inhibitory effect on lipid peroxidation induced by various model systems were examined. Uric acid efficiently scavenged carbon-centered and peroxyl radicals derived from the hydrophilic free radical generator 2,2'-azobis-(2-amidinopropane)-dihydrochloride (AAPH). All damage to biological molecules, including protein, DNA and lipids induced by AAPH, was strongly prevented by uric acid. In contrast, alpha-tocopherol had little effect on damage to biological molecules. Lipid peroxidation by the lipophilic free radical generator 2,2'-azobis(2,4-dimethylvaleronitrile) (AMVN) was little inhibited by uric acid, but not by alpha-tocopherol. Copper-induced lipid peroxidation was inhibited by uric acid and alpha-tocopherol. NADPH- and ADP-Fe(3+)-dependent microsomal lipid peroxidation was efficiently inhibited by alpha-tocopherol, but not by uric acid. Uric acid seems to scavenge free radicals in hydrophilic conditions to inhibit lipid peroxidation on the lipid-aqueous boundary, and the antioxidation is only little in lipophilic conditions.     

CX-659S: a novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities

We investigated the antioxidative activities and the effects on acute inflammation in mice of a novel diaminouracil derivative, CX-659S ((S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4(1H,3H)-pyrimidinedione). CX-659S showed potent scavenging activities against the hydroxyl radical and peroxynitrite and inhibited lipid peroxidation in rat brain homogenates in vitro. Topically applied CX-659S dose-dependently inhibited arachidonic acid- and 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ear edema in mice. Consistent with its antioxidative properties in vitro, CX-659S dramatically attenuated the accumulation of lipid peroxides in the mouse ear elicited by repeated application of TPA. Previously, we reported the effectiveness of CX-659S against contact hypersensitivity reactions in both mouse and guinea pig models. These present results further suggest the therapeutic potential of CX-659S for acute skin inflammation that may involve oxidative tissue damage.     

Histamine release from rat mast cells induced by metabolic activation of polyunsaturated fatty acids into free radicals.

Polyunsaturated fatty acids (PUFA: arachidonic and linoleic acid) release histamine from isolated purified rat serosal mast cells only in the presence of oxidizing systems such as phenobarbital-induced rat liver microsomes, prostaglandin-H-synthetase (PHS) or soybean lipoxygenase. The release of mast cell histamine by activated PUFA has a long time-course and the electron microscopical features are consistent with an exocytotic secretion in the case of arachidonic acid and cell lysis in the case of linoleic acid. The phenomenon is associated with a significant increase in malonyldialdehyde (MDA) and conjugated diene generation, suggesting a relationship between histamine release and membrane lipid peroxidation. The secretion of histamine was inhibited by anti-free radical interventions such as D-mannitol, reduced glutathione and alpha-tocopherol. Some cyclooxygenase and lipoxygenase inhibitors, cimetidine and carnitine derivatives, are differentially active in the inhibition of mast cell histamine release by activated arachidonic acid. These results suggest that free radical derivatives of PUFA, generated by metabolic activation, trigger mast cell histamine release.     

Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.

Leukotrienes (LTs) and platelet-activating factor (PAF) are important mediators of inflammation and allergy. LDP-392, a novel dual PAF receptor antagonist and 5-lipoxygenase (5-LO) inhibitor, has been identified. LDP-392 is 17.9-fold more potent than zileuton (5-LO inhibitor) in the RBL cytosolic 5-LO assay, and equally potent as MK 287 (PAF receptor antagonist) in the human platelet PAF receptor binding assay. The in vivo dual activities of LDP-392 were confirmed by measuring the inhibition of ex vivo LTB(4)production in rats and PAF-induced hemoconcentration in mice. Intravenous administration of LDP-392 demonstrated greater inhibition than zileuton, BN 50739 or MK 287 on arachidonic acid-induced ear edema and protected mice from LPS-induced lethality. Topical administration of LDP-392, in a dose-dependent manner, inhibited TPA-induced ear edema in mice and UVB-induced erythema in guinea-pigs. These data suggest that LDP-392, as a dual PAF receptor antagonist and 5-LO inhibitor, may be of greater clinical effectiveness.     

Inhibition of cephaloridine-induced lipid peroxidation

The present study was designed to elucidate whether cephaloridine-induced lipid peroxidation is inhibited by probenecid, cobalt chloride and antioxidants such as alpha-tocopherol and N,N'-diphenyl-p-phenylenediamine (DPPD). Kidney slices obtained from the renal cortex of male Wistar rats were incubated for 1 h in a cephaloridine or cefotaxime (1.25-10 mg/ml) containing medium. In another series of experiments, kidney slices were incubated with cephaloridine or cefotaxime (5 mg/ml) for different periods of time (30-120 min). Lipid peroxidation was monitored by measuring the production of malondialdehyde (MDA). Subsequently, kidney slices were incubated in both series of experiments, in a cephalosporin free medium containing tetraethylammonium (TEA). Accumulation of TEA in renal cortical slices, expressed as slice to medium ratio (S/M), was used to measure changes in the transport capacity of the kidney cells. While cefotaxime had only a slight effect, cephaloridine induced a significant time- and concentration-dependent increase of MDA production and a significant time- and concentration-dependent decrease of TEA accumulation. Inhibition of the renal uptake of cephaloridine by probenecid induced a decrease in MDA production and complete recovery of TEA accumulation. The antioxidants DPPD and alpha-tocopherol inhibited cephaloridine-induced lipid peroxidation in a concentration-dependent manner. Recovery of TEA accumulation accompanied the decrease in lipid peroxidation. DPPD was a more potent inhibitor of lipid peroxidation than alpha-tocopherol. Cobalt chloride, known for its ability to decrease cellular concentration of cytochrome P-450, effectively decreased cephaloridine-induced lipid peroxidation. Thus, these findings support the concept that lipid peroxidation has an important role in the development of cephaloridine-induced nephrotoxicity.     

Anti-proliferative, anti-inflammatory and antioxidant effects of curcumin analogue A2

In the present study, we determined the anti-proliferative, anti-inflammatory and antioxidant effects of a curcumin analogue, 2,6-bis(3,4-dihydroxybenzylidene) cyclohexanone (designated as A₂). In vitro studies showed that A₂ had a stronger inhibitory effect on the growth of mouse macrophage RAW 264.7 cells than curcumin. A₂ also showed a stronger inhibitory effect than curcumin on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced increases in NF-κB activation and IL-1β expression as well as in aldose reductase activity. A₂ was a stronger antioxidant than curcumin as determined by inhibition of lipid peroxidation, inhibition of 1,1-diphenyl-2-picryl-hydrazyl free radical formation, and inhibition of 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) radical formation. In vivo studies indicated that A₂ was more potent than curcumin for inhibiting TPA-induced ear edema and TPA-induced increases in IL-1β. In addition, oral administration of A₂ at a dose of 2,000 mg/kg body weight did not cause acute toxicity in mice. Taken together, the results of our study indicate that the curcumin analogue A₂ has stronger anti-proliferative, anti-inflammatory and antioxidant activities than curcumin.     

重组人超氧化物歧化酶在大鼠和小鼠的抗炎作用及机理研究

目的:研究重组人超氧化物歧化酶(rhSOD)的抗炎作用及其作用机理.方法:采用角叉菜胶诱导的大鼠和小鼠关节炎、巴豆油诱发的小鼠耳肿模型,研究药物对炎症肿胀度的影响.大鼠炎症渗出液中NOS活性用NADPH黄递酶染色法、β-NAG用对硝基酚比色法、MDA用TBA荧光法测定,IL-1β和TNFα含量用放射免疫法测定.结果:rhSOD 20-80mg/kg ip对大鼠关节炎,10-80mg/kg im对小鼠耳肿、80mg/kg ip对小鼠足肿有显著的抑制作用.同时大鼠炎症渗出液中NOS活性降低,IL-1β和TNFα含量显著减少.其抑制IL-1β中成的作用明显强于地塞术松2mg/kg ip.rhSOD使炎症组织内中性粒细胞浸润减轻,MDA生成减少,闲不影响炎症渗出液中β-NAG活性.结论:rhSOD对大鼠和小鼠实验性炎症有明显的抗炎作用.其抗炎作用机理和清除氧自由基、抗脂质过氧化有关,也和抑制炎症细胞浸润、减少炎症性细胞因子如IL-1β和TNFα的生成有关.     

In vitro free radical scavenging activities and effect of synthetic oligosaccharides on antioxidant enzymes and lipid peroxidation in aged mice

In this study we synthesized oligosaccharides using glucose as reactant via a route assisted by microwave irradiation and evaluated their antioxidant activity in vivo and in vitro. The results show that the oligosaccharides exhibited antioxidant activity in vitro as compared to standard antioxidants such as butylated hydroxytoluene (BHT), and alpha-tocopherol. This antioxidant activity depended on concentration and increased with increasing dose of sample. In addition, increased endogenous lipid peroxidation and decreased total antioxidant capacity (TAOC) were observed in aged mice. Thirty-day intraperitoneal administration of the oligosaccharides significantly decreased the lipid peroxidation in a dose-dependent manner. Oligosaccharides treatment increased TAOC and the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in all organs tested in aged mice. The present study suggests that the synthetic oligosaccharides possess promising future for their strong free radical scavenging activity. Therefore they can be employed in compensating the decline in TAOC and the activities of antioxidant enzymes and in reducing the risks of lipid peroxidation.     

Effect of piperonyl butoxide or allopurinol on cyanide-induced lipid peroxidation in mouse brain

The effect of piperonyl butoxide or allopurinol on cyanide-induced lipid peroxidation was investigated using homogenates from whole brain of mice. The brain homogenate exposed to a low concentration of potassium cyanide (10, 50, or 100 μM) was significantly increased in their concentration of malondialdehyde (MDA)+4-hydroxyalkenals (4-MDA) as compared to control samples, in a concentration-dependent manner. The increased lipid peroxidation induced by cyanide was inhibited by piperonyl butoxide (1 mM), an inhibitor of mixed function oxidase, but not by allopurinol (0.1 mM), an inhibitor of xanthine oxidase. Furthermore, when a brain homogenate heated at 86°C for 1 min was incubated with or without cyanide at 37°C for 20 min, MDA+4-MDA levels in the homogenate were not changed between cyanide treatment and untreated. An intraperitoneal injection of piperonyl butoxide (1 g/kg) significantly inhibited cyanide-induced seizures in mice. These results suggest that cyanide-induced seizures may be partly involved in the lipid peroxidation produced by the heat unstable and piperonyl butoxide dependent factors in brain.     

In vivo production of ethylene from 2-keto-4-methylthiobutyrate in mice

The use of 2-keto-4-methylthiobutyric acid (KMB), the alpha-keto analog of methionine, was studied as a potential means of detecting free radical generation in vivo. KMB-dependent ethylene production (presumably from free radical interception), and ethane production from in vivo lipid peroxidation, were monitored simultaneously by measuring the rate of exhalation of these hydrocarbons by mice. Injection of KMB (1 g/kg) into mice resulted in an 8-fold increase in ethylene production above endogenous levels seen in saline-injected controls (1.47 +/- 0.35 vs 0.17 +/- 0.02 nmoles/100 g/hr respectively). Administration of CCl4 (3.0 g/kg) to initiate hepatic lipid peroxidation, 20 min prior to KMB injection, augmented the production of ethylene (2.37 +/- 0.10 nmoles/100 g/hr). Lipid peroxidation following injection of CCl4 was monitored via the increased exhalation of ethane. Pretreating the mice with vitamin E (100 mg/kg daily for 3 days), an inhibitor of lipid peroxidation, did not result in a significant change in ethylene production from KMB by itself or after prior injection of CCl4. However, vitamin E did suppress ethane production initiated by CCl4. Similar results were obtained with mouse liver slices studied in vitro. Metyrapone (150 mg/kg), an inhibitor of hepatic mixed function oxidase activity, also suppressed significantly the CCl4-stimulated production of ethane, but not the CCl4-stimulated production of ethylene from KMB. It appears that ethylene production from KMB does not derive from free radicals generated during in vivo lipid peroxidation since suppression of lipid peroxidation by vitamin E or metyrapone did not suppress ethylene production.     

In vitro studies on the influence of L-ascorbic acid 2-[3,4-dihydro- 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl-hy drogen phosphate] potassium salt on lipid peroxidation and phospholipase A2 activity.

The effects of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2- (4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl-hydrogen phosphate] potassium salt (EPC-K1, CAS 127061-56-7), a new compound for ischemia-reperfusion injuries, on lipid peroxidation and phospholipase A2 activity were studied in vitro using rat brain homogenates and human plasma. EPC-K1 inhibited phospholipase A2 activity in human plasma in a concentration-dependent manner (IC50 = 7.3 x 10(-4) mol/l), whereas a mixture of alpha-tocopherol and ascorbic acid did not exhibit this effect. In rat brain homogenates, EPC-K1 also inhibited lipid peroxidation in a concentration-dependent manner (IC50 = 2.3 x 10(-6) mol/l). alpha-Tocopherol was less active than EPC-K1. These properties of EPC-K1 suggest that EPC-K1 may prove useful in the treatment of ischemia-reperfusion injuries.     

葡萄籽中原花青素的抗炎作用和机制

目的：研究葡萄籽中原花青素（PA）的抗炎作用及机制。方法：用巴豆油诱导的小鼠耳肿和角叉菜胶诱导的大鼠足肿模型,研究PA对炎症的影响。NOS活性用NADPH黄递酶染色法,NO含量用Griess重氮化反应法,β-NAG用对硝基酚比色法,MDA用TBA荧光法测定,IL－1β,TNFα和PGE2含量用放免法测定。结果：PA 10－40mg/kg ip剂量依赖性地抑制角叉菜胶诱导的大鼠足肿和巴豆油诱导的小鼠耳肿。PA 10mg/kg减少大鼠致炎足MDA生成,抑制炎症渗出液中NOS的β－NAG活性,降低IL－1β、TNF和PGE2含量。其作用强于地塞米松2mg/kg。结论：PA对大鼠和小鼠实验性炎症有明显的抗炎作用。其抗炎机理和清除氧自由基、抗脂质过氧化和减少细胞因子的生成有关。     

Effect of alpha-tocopherol pretreatment on infarct size following 90 minutes of ischemia and 4 hours of reperfusion in dogs

The present study was designed to evaluate the effects of pretreatment with antioxidants on free radical mediated reprefusion injury. Five dogs were fed with alpha-tocopherol (1000 IU/kg, bw) for ten days prior to 90 min of left anterior descending coronary artery occlusion followed by 4 hours of reperfusion. Infarct size, serum and myocardial lipid peroxidation were measured in pretreated and in untreated animals. Infarct size, as percentage of myocardial tissue at risk in alpha-tocopherol pretreated animals was 5.86+/-0.83 and was 39.35+/-7.58 in the untreated animals. Following reprefusion in untreated group, the values of serum and myocardial tissue lipid peroxidation were significantly higher than observed values in alpha-tocopherol treated animals. alpha-tocopherol pretreatment significantly reduced the myocardial infarct size and percent necrosis in the left ventricular mass in comparison to the untreated animals. These results suggest that alpha-tocopherol pretreatment possibly helps in reducing infarct size.     

Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation

Glucosamine (GS) is well known for the treatment of inflam-mation. However, the mechanism and efficacy of GS for skin inflammation are unclear. The aim of this study was to evaluate the effects and mechanism of GS in the mouse 12-O-tetradecanoyl 13-acetate (TPA)-induced ear edema model. TPA-induced ear edema was evoked in ICR or transglutaminase 2 (Tgase-2) (-/-) mice. GS was administered orally (10-100 mg/kg) or topically (0.5-2.0 w/v %) prior to TPA treatment. Orally administered GS at 10 mg/kg showed a 76 or 57% reduction in ear weight or myeloperoxidase, respectively, and a decreased expression of cyclooxy-genase-2 (COX-2), NF-κB and Tgase-2 in TPA-induced ear edema by western blot and immunohistochemistry. Role of Tgase-2 in TPA ear edema is examined using Tgase-2 (-/-) mice and TPA did not induce COX-2 expression in ear of Tgase-2 (-/-) mice. These observations suggested that Tgase-2 is involved in TPA-induced COX-2 expression in the inflamed ear of mice and anti-inflammatory effects of glucosamine is mediated through suppression of Tgase-2 in TPA ear edema.     

Intervention in free radical mediated hepatotoxicity and lipid peroxidation by indole-3-carbinol

The cytoprotective effect of the natural dietary constituent indole-3-carbinol (I-3-C) on carbon tetrachloride (CCl4) mediated hepatotoxicity in mice was examined. I-3-C pretreatment by gavage 1 hr prior to intraperitoneal injection of CCl4 produced a 63% decrease in CCl4-mediated centrolobular necrosis and a related 60% decrease in plasma alanine aminotransferase activity (a marker of liver necrosis). Since the toxicological effects of CCl4 are mediated by radical species generated during reductive metabolism by cytochrome P-450, we examined the potential ability of I-3-C to scavenge reactive radicals. Three systems were used to evaluate the ability of I-3-C to intervene in free radical mediated lipid peroxidation. These systems consisted of the following: (1) phospholipid dissolved in chlorobenzene, with peroxidation initiated by the thermal and photo decomposition of azobisisobutyronitrile (AIBN); (2) sonicated phospholipid vesicles in phosphate buffer (pH 7.4), with peroxidation initiated by ferrous/ascorbate; and (3) mouse liver microsomes containing an NADPH-regenerating system, with peroxidation initiated with CCl4. Lipid peroxidation was measured in these three systems as thiobarbiturate-reacting material. In the AIBN and ferrous/ascorbate systems, I-3-C inhibited lipid peroxidation, with greater inhibition under conditions of low rates of free radical generation. I-3-C was not as effective an antioxidant as butylated hydroxytoluene (BHT) or tocopherol, but it inhibited peroxidation in a dose-response manner. I-3-C was most effective as a radical scavenger in the microsomal CCl4-initiated system by inhibiting lipid peroxidation in a dose-dependent fashion, with 50% inhibition at 35-40 microM I-3-C. This concentration is about one-third of the concentration of I-3-C achieved in liver after treatment of mice by gavage with 50 mg I-3-C/kg body weight. These data suggest that I-3-C may be a natural antioxidant in the human diet and, as such, may intervene in toxicological or carcinogenic processes that are mediated by radical mechanisms.     

Effects of cadmium on superoxide dismutase and lipid peroxidation in liver and kidney of growing rats: in vivo and in vitro studies

Intraperitoneal administration of cadmium acetate (Cd2+, 0.4 mg/kg) to rats daily for 30 days was found to inhibit the activity of superoxide dismutase (SOD), to increase the endogenous levels of lipid peroxides and lipid peroxidation in the liver and the kidney tissues. Addition of varying concentrations of Cd2+ (10-100 microM) in vitro also inhibited SOD in both the tissues. It appears that the inhibition of SOD could be due to direct interaction of Cd2+ with the enzyme molecule. Lipid peroxidation reaction was also increased after addition of Cd2+ to fresh homogenate of these tissues, however, it did not produce any effect in heated homogenates in in vitro experiments. It indicated that Cd-induced elevation in lipid peroxidation may not be only due to the possibility of higher level of superoxide radicals resulting from inhibited superoxide dismutase but could also be as a result of direct action of Cd2+ on the peroxidation reaction. Thus, the possibility of involvement of free radical damage to the membrane structures in Cd toxicity has been demonstrated in these experiments.     

Scavenging of Free-radicals and Inhibition of Lipid Peroxidation by 3-Phenylsydnone

The antioxidant properties of 3-phenylsydnone were studied in various models in-vitro. 3-Phenylsydnone scavenged the stable free radical, 1,1-diphenyl-2-picrylhydrazyl, and inhibited the degradation of deoxyribose mediated by hydroxyl radicals, although, to a lesser extent than trolox, a water soluble analogue of vitamin E. Many antioxidants possess pro-oxidant properties due to their ability to reduce ferric ions; however, 3-phenylsydnone was free from pro-oxidant properties, and also inhibited the lipid peroxidation induced by iron, in rat brain homogenates.     

Effect of melatonin,piperonyl butoxide,or cobalt chloride on l-cysteine-induced lipid peroxidation in homogenate from whole brain of mice

Brain homogenates exposed to a low concentration of l-cysteine (0.05, 0.1, 0.5, 1.0, and 2.0 mM) were significantly increased in their concentration of malondialdehyde (MDA) + 4-hydroxyalkenals (4-HDA) as compared to control samples, in a concentration-dependent manner. The increased lipid peroxidation by l-cysteine was attenuated or completely abolished by co-incubation with melatonin (2 mM), a potent free radical scavenger, piperonyl butoxide (1 mM), an inhibitor of mixed function oxidase, or cobalt chloride (0.01, 0.02 or 0.05 mM), another inhibitor of mixed function oxidase, but not allopurinol (0.1 mM), an inhibitor of xanthine oxidase. In addition, when a brain homogenate heated at 85 °C for 1 min was incubated with or without l-cysteine at 37 °C for 20 min, MDA + 4-HDA levels in the homogenate was not changed between l-cysteine and control. These results suggest that l-cysteineinduced lipid peroxidation may be involved in the enzymatic mixed function oxidation systems in brain.